Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2022
Number of items: 2.

2022

Ben Khaled, Najib, Seidensticker, Max, Ricke, Jens, Mayerle, Julia, Oehrle, Bettina, Roessler, Daniel, Teupser, Daniel, Ehmer, Ursula, Bitzer, Michael ORCID: 0000-0002-4463-8263, Waldschmidt, Dirk, Fuchs, Martin, Reuken, Philipp A., Lange, Christian M., Wege, Henning, Kandulski, Arne, Dechene, Alexander, Venerito, Marino, Berres, Marie-Luise, Luedde, Tom ORCID: 0000-0002-6288-8821, Kubisch, Ilja, Reiter, Florian P. and De Toni, Enrico N. (2022). Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol. Future Oncol., 18 (12). S. 1423 - 1436. LONDON: FUTURE MEDICINE LTD. ISSN 1744-8301

De Toni, Enrico N., Kubisch, Ilja, Ben Khaled, Najib, Ricke, Jens, Mayerle, Julia, Ehmer, Ursula, Waldschmidt, Dirk, Roessler, Daniel Christoph, Oehrle, Bettina, Bitzer, Michael, Kandulski, Arne, Reuken, Philipp A., Wege, Henning and Seidensticker, Max (2022). Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: The DEMAND randomized phase II clinical trial. J. Clin. Oncol., 40 (4). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

This list was generated on Thu Feb 29 17:16:13 2024 CET.